Clinical Trial

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is testing a personalized form of brain stimulation called PrTMS as a treatment for post-traumatic stress disorder (PTSD) in military service members and veterans. Unlike standard approaches, this treatment uses a simple brainwave test (EEG) to tailor the therapy to each individual. Participants will be randomly assigned to receive either active treatment or a comparison (sham) treatment over 6 weeks. Researchers will track changes in PTSD symptoms, mood, sleep, and overall well-being, including using wearable devices to measure things like sleep and heart rate. The goal is to see whether this personalized approach can provide greater and longer-lasting relief for individuals living with PTSD.
Trial Details
NCT Number NCT07526285
Lead Sponsor Massachusetts General Hospital
Collaborators: United States Air Force Research Laboratory
Conditions Posttraumatic Stress Disorder (PTSD)
Enrollment 100 participants
Start Date 2026-08-01
Primary Completion 2028-07-31 (estimated)
Study Completion 2029-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13